News
Strides Pharma Science consolidated net profit rises 77.52% in the September 2025 quarter
31-Oct-2025 | 14:29
Sales rise 4.62% to Rs 1220.83 crore
Net profit of Strides Pharma Science rose 77.52% to Rs 127.53 crore in the quarter ended September 2025 as against Rs 71.84 crore during the previous quarter ended September 2024. Sales rose 4.62% to Rs 1220.83 crore in the quarter ended September 2025 as against Rs 1166.93 crore during the previous quarter ended September 2024.
| Particulars | Quarter Ended | ||
| Sep. 2025 | Sep. 2024 | % Var. | |
| Sales | 1220.83 | 1166.93 | 5 |
| OPM % | 18.88 | 15.76 | - |
| PBDT | 211.53 | 138.53 | 53 |
| PBT | 161.89 | 90.08 | 80 |
| NP | 127.53 | 71.84 | 78 |
Powered by Capital Market - Live News